Nureca Ltd Share Price & Stock Analysis

Nureca Ltd (NSE: NURECA, BSE: 543264) is a Chandigarh-based company in the Medical Testing, Analyzing, and Diagnostic Equipment industry. With a market capitalisation of ₹306 Cr, it ranks #2,330 by market cap among the 6,137 Indian listed companies on FinBizNet, and #5 of 7 in Medical Testing, Analyzing, and Diagnostic Equipment. At ₹316.70 (as of 25 Oct 2026), the share price is 15.8% below its 52-week high of ₹376.00 and 55.2% above its 52-week low of ₹204.00. The share price is up 30.6% over one year and up 5.0% over three months.

Key Metrics

Current Price₹316.70
Market Cap₹306 Cr
NSE SymbolNURECA
BSE Code543264
SectorHealth Care > Health Care Equipment and Services > Health Care Equipment and Supplies
Sub-IndustryHealth Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment
P/E Ratio148.5
Return on Equity1.11%
Return on Assets-0.56%
52-Week Range₹204.00 – ₹376.00
1-Year Price Change+30.6%
3-Month Price Change+5.0%
Beta (1Y)0.89
Dividend Yield0.00%
HeadquartersChandigarh
Websitewww.nureca.com

Latest Quarterly Results — Q2 FY27

Revenue₹59 Cr
Net Profit₹4 Cr
Net Margin6.9%
EPS (Basic)₹4.25
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

About Nureca Ltd

Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, fitness trackers, and smart weighing scales. In addition, the company provides orthopedic cushions, heating pads, and breast pumps. The company offers its products under the Dr Trust, Dr Physio, and Trumom brands. It markets its products through e-commerce platforms,

Products and Services

1. Home Healthcare and Wellness Products-This segment provides home healthcare and wellness products. It sells its products through e-commerce players, distributors, and retailers.

Business Segments

1. Home Healthcare and Wellness Products-100%

Nureca Ltd vs Peers — Medical Testing, Analyzing, and Diagnostic Equipment

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Molbio Diagnostics Limited₹18,143 Cr97.3—₹408 Cr—
Hemant Surgical Industries Lim₹857 Cr41.4——+88.9%
Credent Connect N Care₹620 Cr24.4———
QMS Medical Allied Services Limited₹331 Cr33.2—₹57 Cr+70.1%
Nureca Ltd₹306 Cr148.51.11%₹59 Cr+30.6%
Earkart Limited₹172 Cr31.4—₹0 Cr-41.6%
Avience Biomedicals Limited₹146 Cr12.1———

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Nureca Ltd?

Nureca Ltd is trading at ₹316.70, with a market capitalisation of ₹306 Cr.

Which sector does Nureca Ltd belong to?

Nureca Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment).

What are the key financial ratios of Nureca Ltd?

Nureca Ltd has a P/E of 148.5 and a return on equity of 1.11%.

What is the stock symbol of Nureca Ltd?

Nureca Ltd is listed on the NSE under the symbol NURECA and on the BSE under the scrip code 543264.

How has Nureca Ltd's share price moved over the past year?

Nureca Ltd's share price is up 30.6% over one year and up 5.0% over three months. Its 52-week range is ₹204.00 to ₹376.00.

What were Nureca Ltd's latest quarterly results?

In Q2 FY27, Nureca Ltd reported revenue of ₹59 Cr and net profit of ₹4 Cr, with basic EPS of ₹4.25 (consolidated, parsed from the company's exchange filing).

More on FinBizNet

Data as of 25 Oct 2026. Descriptive market data only — not investment advice.